Embrace Meeting - First Line Trials in post Menopausal Women

Speciality: Obstetrics and Gynecology


Speaker:

Dr. Chintan Shah - Moderator | Medical Oncologist HOC Vedanta

Dr. Murtaza Bohra - Case Presenter | Medical Oncologist National Cancer Institute

Dr. Ashish B. Agrawal - Expert Panelist | Medical Oncologist & Haematologist Kiran Multispecialty Hospital

Dr. Shivam Shingla - Expert Panelist | Medical Oncologist S L Raheja Hospital

Dr. Avinash Talele - Expert Panelist | Medical Oncologist Apollo Hospital

Description:

A warm welcome to all the medical professionals in this interesting session on Embrace Meeting - First Line Trials in post Menopausal Women 
The Embrace Meeting is a significant event that brings together experts to discuss the latest advancements in the treatment of postmenopausal women, focusing particularly on first-line clinical trials. This meeting provides a platform for sharing cutting-edge research, clinical experiences, and innovative strategies aimed at improving healthcare outcomes for this demographic.
 A key highlight of the Embrace Meeting is the discussion of first-line clinical trials specifically tailored for postmenopausal women. These trials explore the efficacy and safety of new therapeutic options in treating conditions prevalent in this group, such as osteoporosis, breast cancer, and cardiovascular disease. The aim is to identify optimal first-line treatments that offer the best balance of efficacy and tolerability.
These advancements represent potential game-changers in the management of health issues in postmenopausal women, offering hope for improved quality of life.
Therefore, get an overall knowledge of embrace meeting - first line trials in post menopuasal women
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment

2.

A small rise in cancer was observed following the 1986 Chernobyl accident.

3.

First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.

4.

New research uncovers link between cancer pathway and blood-retina barrier function

5.

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot